About the AB

New ABPI report finds £2bn in fresh pharma investment since September 2025, but warns the UK's recovery depends on delivering committed reforms.

A shift in how NICE measures treatment benefits could restrict access to some medicines, particularly those improving quality of life without extending survival. Alan Lamb explains the change from EQ-5D-3L to 5L and why the ABPI believes it needs careful

The UK holds one of the world's most valuable health data assets, with GP records capturing around 90% of a patient's NHS interactions over their lifetime. ABPI Director Janet Messer explains why the new Health Data Research Service is a once-in-a-generat

The NHS Federated Data Platform, the Single Patient Record and the Health Data Research Service have become hot topics of discussion in recent times. This article explains what each one is, and how they relate, or not, to the UK's pharmaceutical industry.

Joanna Jenkinson discusses plans for a new £20 million pre-clinical translational models hub in Cambridge, a concept the ABPI and its members have long championed. Led by the Medical Research Council, the hub will develop human-relevant models, including

In this piece, Victoria Jordan, ABPI's Director, Value and Access Policy, explains why the government must increase NICE's baseline threshold to ensure that NHS patients benefit from timely access to the latest treatments.

Kim Assender, Director of Commercial Policy and Analysis at the ABPI, discusses a new report from IQVIA and what it says about the right strategic level of spending on medicines to deliver the best outcomes for patients while supporting cash-strapped heal

The ABPI has appointed Laura McMullin as Vice-President of the ABPI.

This blog explores how the government's Growth and Skills Levy can help to achieve this ambition by making education and training more accessible while building on the success of apprenticeships in the life sciences sector

Employers looking to attract young talent into life sciences careers must embrace authenticity and social media channels, according to a new report.